Study to Evaluate Organic Anion Transporting Polypeptide (OATP) Transporter-Mediated Drug-Drug Interactions Between Filgotinib and Statins as Probe Drugs in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

November 4, 2020

Primary Completion Date

January 13, 2021

Study Completion Date

January 13, 2021

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Atorvastatin

Administered as single dose tablet orally.

DRUG

Pravastatin

Administered as single dose tablet orally.

DRUG

Rosuvastatin

Administered as single dose tablet orally.

DRUG

Filgotinib

Administered as tablet orally once daily for 11 days.

Trial Locations (1)

55114

Prism Research, LLC, Saint Paul

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Galapagos NV

INDUSTRY

lead

Gilead Sciences

INDUSTRY